Clinical Trials

Data shown at the 64th American Society of Haematology (ASH) conference in New Orleans demonstrates that elranatamab is effective and has a controllable effectiveness and safety in patients with relapsed or refractory multiple myeloma (RRMM). Multiple myeloma (MM) is a...

BioNTech SE announced the initiation of a first-in-human Phase 1 study with BNT165b1, the first candidate from the Company’s BNT165 program, to develop a multi-antigen malaria vaccine candidate. BioNTech will initially evaluate a set of mRNA-encoded antigens of the...

Ceapro Inc., a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced it has received approval from Health Canada to initiate its Phase 1/2a study evaluating the safety, tolerability, bioavailabilty...

Based on recommendations from an independent study report titled Enhancing Aotearoa New Zealand Clinical Trials, New Zealand's top health agencies will examine system-level adjustments to enhance the benefits from clinical trials. The report was created by a broad team of...

To take advantage of the UK's quick medication approval procedures, the North American psychedelic drug companies Mindset, PharmAla, Mydecine, and Psyence have inked a contract with the clinical research organisation (CRO) Clerkenwell Health to test treatments for mental health...

Immix Biopharma, Inc, a biopharmaceutical company pioneering Tissue-Specific Therapeutics (TSTx)TM targeting oncology and immuno-dysregulated diseases, announced patient dosing in its ongoing Phase 1b/2a IMX-110 monotherapy clinical trial. This is the fifteenth patient dosed with IMX-110 to-date. IMX-110 clinical trial...

The growth in ongoing clinical trials for oligonucleotide-based therapies in important therapeutic fields like oncology is expected to cause the global oligonucleotide synthesis market to reach $16.7 billion by 2027 during the forecast timeframe, according to a recent market...